| Naslov: | Risk of anaphylaxis associated with cold urticaria |
|---|
| Avtorji: | ID Bizjak, Mojca, Univerzitetna klinika za pljučne bolezni in alergijo Golnik (Avtor)
ID Rutkowski, Krzysztof (Avtor)
ID Assero, Ricardo (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://link.springer.com/article/10.1007/s40521-024-00366-9
 PDF - Predstavitvena datoteka, prenos (803,06 KB)
MD5: 6E2A0B4C9AE7F899508631F5BDFD49BD
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: |  UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
|
|---|
| Povzetek: | Purpose of review
Cold-induced anaphylaxis (ColdA) is a poorly understood form of anaphylaxis that occurs in patients with cold urticaria (ColdU). This comprehensive review aims to deepen the understanding of ColdA. It emphasizes the identification of high-risk ColdU patients susceptible to ColdA and provides recommendations for their effective management.
Recent findings
Recent studies, including the large international COLD-CE study, have identified clinical features of ColdU patients associated with increased ColdA risk. These individuals can now be recognized through routine clinical assessments. Key diagnostic indicators for assessing ColdU and the risk of ColdA include oropharyngeal/laryngeal symptoms and positive standard local cold provocation tests. ColdA has been defined as acute cold-induced involvement of the skin and/or visible mucosal tissue accompanied by cardiovascular manifestations, difficulty breathing, or gastrointestinal symptoms, but a universally accepted definition is lacking. Additionally, ColdA has recently been recognized as an indication for prescribing adrenaline (epinephrine) autoinjectors, marking a significant advancement in disease management.
Summary
ColdA is a major and potentially life-threatening concern for a subset of ColdU patients. Early recognition of high-risk patients, coupled with education and preparedness of both patients and healthcare providers, is crucial for effectively managing this challenging condition. Further research is needed to expand understanding of the underlying pathophysiological mechanisms of ColdA, identify potential cofactors influencing ColdA, and improve disease-management strategies. |
|---|
| Ključne besede: | adrenaline (epinephrine), autoinjector, cold-induced anaphylaxis, cold urticaria, management, risk factors |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Datum sprejetja članka: | 06.06.2024 |
|---|
| Datum objave: | 20.06.2024 |
|---|
| Založnik: | Springer |
|---|
| Leto izida: | 2024 |
|---|
| Št. strani: | str. 167–175 |
|---|
| Številčenje: | Vol. 11, [iss. 3] |
|---|
| Izvor: | Current treatment options in allergy |
|---|
| PID: | 20.500.12556/DiRROS-22523  |
|---|
| UDK: | 616 |
|---|
| ISSN pri članku: | 2196-3053 |
|---|
| DOI: | 10.1007/s40521-024-00366-9 |
|---|
| COBISS.SI-ID: | 200488451 |
|---|
| Avtorske pravice: | © The Author(s) 2024
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
|---|
| Datum objave v DiRROS: | 28.05.2025 |
|---|
| Število ogledov: | 450 |
|---|
| Število prenosov: | 265 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
